Gateway to Translation (G2T) Webinar - February 2025
Gateway to Translation
Translating Cell and Gene Therapies to the Clinic: Common Challenges and Potential Solutions
Join us for this month's Gateway to Translation (G2T), on Wednesday 26th February at 2pm. Guest speaker, Dr Zoe Hewitt, Co-Founder and CEO at Regenerative Cell Therapy Consulting (Regen CTC) Limited., will deliver a talk on the topic of “Translating Cell and Gene Therapies to the Clinic: Common Challenges and Potential Solutions”
About Zoe and Regen CTC
Zoe has a background in Pluripotent Stem Cells, which started in 2001 when she obtained her PhD from the Roslin Institute/ University of Edinburgh. After completing her studies, she worked with a team developing differentiation protocols for hepatocytes, before moving to the University of Sheffield in 2006, where she established and managed a clean room facility, which was responsible for deriving the UK's first clinically available human Embryonic Stem Cells (MasterShef lines 1 to 14). Within this facility, Zoe and her team were responsible for delivering the starting master cell banks (Shef1) for the London Project to Cure Blindness. This resulted in the first successful UK clinical trial of an hPSC-derived retinal pigment epithelium (RPE) cell replacement therapy.
In 2015, Zoe moved away from active research becoming a Project Manager for the UK Regenerative Medicine Platform (UKRMP), firstly for the Pluripotent Stem Cell Platform (PSCP) winning the UKRMP Special Merit Award in 2017 and then for the Pluripotent Stem Cell and Engineered Cell (PSEC) Hub. The goal of the UKRMP Hubs was to advance regenerative medicine therapies by delivering innovative approaches to the rate-limiting steps of hPSC-based cell replacement therapies to enable clinical delivery and commercial development. As part of the sustainability strategy for UKRMP, Zoe co-founded Regenerative Cell Therapy Consulting limited in May 2022, which aims to assist innovative research to translate from laboratory research, through to commercial development and investment.
Regen CTC’s network includes fundamental scientists, manufacturing engineers, clinicians and expert translational scientists with real world experience. They have extensive experience in developing quality management systems, clean room operations and process development of research protocols. You can find further information on the Regen CTC website.
About the Gateway to Translation (G2T) webinar series
The “Gateway to Translation” (G2T) webinar series is a joint initiative between the University of Cambridge (Cambridge Academy of Therapeutic Sciences, CATS) and the University of Manchester (Translation Manchester). The aim of these monthly webinars is to stimulate the translation of research into the clinics by educating academics about trends, technologies and research in the commercial sphere and by facilitating collaborations between academia and the medtech, biotech and pharma industry sectors. Recordings from previous webinars are available on the Translation Manchester and CATS websites.
Register your place!